Cite
HARVARD Citation
Marrone, A. et al. (2018). Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy. Journal of viral hepatitis. 25 (2), pp. 198-204. [Online].